Table 2.
Dominant strain | Original strain | Delta variant | Delta variant |
---|---|---|---|
Study period (Dates covered) |
Period OS (Nov. 25, 2020–Jan. 19, 2021) |
Period D1 (Aug. 01–Sept. 25, 2021) |
Period D2 (Sept. 26–Nov. 20, 2021) |
Estimated CICT impact | |||
Cases averted | 7810 | 1437 | 9970 |
Percentage reduction in COVID-19 cases* | 55.4% | 14.6% | 40.4% |
*The number of cases averted by CICT among every 100 cases not averted by vaccine or other nonpharmaceutical interventions (NPIs; such as facemask policies, large gathering restrictions, and school/business closures).